Kermode Biotechnologies

Overview
Livestock Biotech?
Product stageSegments
Minimum Viable Product
?
Next-generation vaccines and drugs
?

Kermode Biotechnologies is a privately held American biotechnology company developing solutions for animal health, specifically targeting livestock viruses such as African Swine Fever Virus (ASFV) and Swine Flu. Its current pipeline comprises two products (therapeutic antibodies and immune-stimulating vaccine proteins) targetting ASFV. Kermode employs computational techniques to pinpoint vulnerable targets within viral structures, genetic compositions, and replication cycles and uses antibody discovery platforms to isolate potent therapeutic candidates, capable of safeguarding livestock from viral infections. This approach enables Kermode to identify robust antibody therapeutics and construct vaccine candidates that elicit durable in vivo responses.

Funding and financials

In May 2021, the company raised USD 1.2 million in venture funding backed by four investors.

HQ location:
1399 GLENARM COURT Erie CO USA
Founded year:
2018
Employees:
1-10
IPO status:
Private
Total funding:
USD 1.2 mn
Last Funding:
USD 1.2 mn (Seed; May 2021)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.